HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by Griffith, M. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by Griffith, M.

A Simple, Cross-linked Collagen Tissue Substitute for Corneal Implantation

¹From the National Research Council Canada, Ottawa, Ontario, Canada; the ²Department of Ophthalmology, Linköping University Hospital, Linköping, Sweden; the ³University of Ottawa Eye Institute, Ottawa, Ontario, Canada; the ⁴University of Tennessee Health Center, Memphis, Tennessee; and the ⁵Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.

PURPOSE. To develop a simple corneal substitute from cross-linked collagen.

METHODS. Porcine type I collagen (10%; pH 5), was mixed with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS). The final homogenous solution was molded to corneal dimensions, cured, and then implanted into rabbits and minipigs by lamellar keratoplasty. The implants were followed for up to 6 months after surgery. Clinical examinations of the cornea included detailed slit lamp biomicroscopy, in vivo confocal microscopy, topography and esthesiometry for nerve function. Histopathologic examinations were also performed on rabbit corneas harvested after 6 months.

RESULTS. Cross-linked collagen (refractive index, 1.35) had optical clarity superior to human corneas. Implanted into rabbit and porcine corneas, only 1 of 24 of the surgical corneas showed a slight haze at 6 months after surgery. All other implants showed no adverse reactions and remained optically clear. Topography showed a smooth surface and a profile similar to that of the contralateral nonsurgical eye. The implanted matrices promoted regeneration of corneal cells, tear film, and nerves. Touch sensitivity was restored, indicating some restoration of function. The corneas with implants showed no significant loss of thickness and demonstrated stable host–graft integration.

CONCLUSIONS. Collagen can be adequately stabilized, using water soluble carbodiimides as protein cross-linking reagents, in the fabrication of corneal matrix substitutes for implantation. The simple cross-linking methodology would allow for easy fabrication of matrices for transplantation in centers where there is a shortage of corneas, or where there is need for temporary patches to repair perforations in emergency situations.

This article has been cited by other articles:

				K. Merrett, P. Fagerholm, C. R. McLaughlin, S. Dravida, N. Lagali, N. Shinozaki, M. A. Watsky, R. Munger, Y. Kato, F. Li, et al. Tissue-Engineered Recombinant Human Collagen-Based Corneal Substitutes for Implantation: Performance of Type I versus Type III Collagen Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3887 - 3894. [Abstract] [Full Text] [PDF]

				S. V. Patel, J. C. Erie, J. W. McLaren, and W. M. Bourne Keratocyte Density and Recovery of Subbasal Nerves After Penetrating Keratoplasty and in Late Endothelial Failure Arch Ophthalmol, December 1, 2007; 125(12): 1693 - 1698. [Abstract] [Full Text] [PDF]

				N. S. Lagali, M. Griffith, N. Shinozaki, P. Fagerholm, and R. Munger Innervation of Tissue-Engineered Corneal Implants in a Porcine Model: A 1-Year In Vivo Confocal Microscopy Study Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3537 - 3544. [Abstract] [Full Text] [PDF]